Cellular & Molecular Biology Letters

Papers
(The H4-Index of Cellular & Molecular Biology Letters is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Correction: Laboratory methods to decipher epigenetic signatures: a comparative review214
Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment184
Targeting UBR5 in hepatocellular carcinoma cells and precise treatment via echinacoside nanodelivery147
Identification of COX4I2 as a hypoxia-associated gene acting through FGF1 to promote EMT and angiogenesis in CRC133
Insight into the physiological and pathological roles of the aryl hydrocarbon receptor pathway in glucose homeostasis, insulin resistance, and diabetes development111
Downregulation of exosomal miR-7-5p promotes breast cancer migration and invasion by targeting RYK and participating in the atypical WNT signalling pathway75
The current landscape of microRNAs (miRNAs) in bacterial pneumonia: opportunities and challenges70
lncRNA PVT1: a novel oncogene in multiple cancers55
Osteoporosis pathogenesis and treatment: existing and emerging avenues46
Melatonin and cancer suppression: insights into its effects on DNA methylation44
tRF-3013b inhibits gallbladder cancer proliferation by targeting TPRG1L41
5-Methoxyflavone-induced AMPKα activation inhibits NF-κB and P38 MAPK signaling to attenuate influenza A virus-mediated inflammation and lung injury in vitro and in vivo41
Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration40
Acquired drug resistance interferes with the susceptibility of prostate cancer cells to metabolic stress40
Diversification of PAR signaling through receptor crosstalk39
Targeting uridine–cytidine kinase 2 induced cell cycle arrest through dual mechanism and could improve the immune response of hepatocellular carcinoma39
Absent in melanoma 2 (AIM2) in rheumatoid arthritis: novel molecular insights and implications36
MF-094 nanodelivery inhibits oral squamous cell carcinoma by targeting USP3034
LncRNA SNHG16 promotes development of oesophageal squamous cell carcinoma by interacting with EIF4A3 and modulating RhoU mRNA stability33
The role of macrophage subtypes and exosomes in immunomodulation29
The transition from HIF-1 to HIF-2 during prolonged hypoxia results from reactivation of PHDs and HIF1A mRNA instability29
The O-glycosylating enzyme GALNT2 acts as an oncogenic driver in non-small cell lung cancer28
Aging of mesenchymal stem cell: machinery, markers, and strategies of fighting27
Exosome application in treatment and diagnosis of B-cell disorders: leukemias, multiple sclerosis, and arthritis rheumatoid26
Inhibition of CISD2 promotes ferroptosis through ferritinophagy-mediated ferritin turnover and regulation of p62–Keap1–NRF2 pathway25
A rare mutation (p.F149del) of the NT5C3A gene is associated with pyrimidine 5′-nucleotidase deficiency25
Metabolic disorders sensitise endometrial carcinoma through endoplasmic reticulum stress25
0.54973292350769